SMTL ID : 8u2e.1

Bruton's tyrosine kinase in complex with N-[(2R)-1-[(3R)-3-(methylcarbamoyl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indol-2-yl]-3-(3-methylphenyl)-1-oxopropan-2-yl]-1H-indazole-5-carboxamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x UP9: (2S)-6-fluoro-5-[(3S)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]-2-(4-methylpiperazine-1-carbonyl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide(Non-covalent)

UP9.1: 16 residues within 4Å: Chain A: L.20, G.21, T.22, V.28, A.40, K.42, T.86, E.87, Y.88, M.89, A.90, N.91, G.92, C.93, N.96, L.140 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.20, A:L.20, A:L.140 Hydrogen bonds: A:T.86, A:E.87, A:M.89, A:M.89, A:C.93

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 6 residues within 4Å: Chain A: T.107, Q.108, L.111, Y.203, V.238, E.270 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.203, A:Y.203 EDO.3: 2 residues within 4Å: Chain A: T.240, Y.243 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.240 Water bridges: A:T.240

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.4: 3 residues within 4Å: Chain A: K.207, P.231, H.232 Ligand excluded by PLIP

1 x IOD: IODIDE ION(Non-functional Binders)

IOD.5: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Robbins, D.W. et al., Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies. J.Med.Chem. (2024)

Release Date

2024-01-31

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence